Induction Therapy
IIT2025004
Phase 2 small_molecule active
Quick answer
Induction Therapy for Splenic B-cell Lymphoma/Leukaemia With Prominent Nucleoli，SBLPN is a Phase 2 program (small_molecule) at China SXT Pharmaceuticals with 1 ClinicalTrials.gov record(s).
Program details
- Company
- China SXT Pharmaceuticals
- Indication
- Splenic B-cell Lymphoma/Leukaemia With Prominent Nucleoli，SBLPN
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active